Drug Database · Clinicians

Cinnarizine

Brands (18) Cinnabloc, Stugeron, Cinnarex…Show all

Anti-vertigo preparation; Antivertigo PH FDA category

Rx · Prescription drug26 PH productsPNF-listed Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Contraindications

  • Hypersensitivity
renalcarematters.com, reviewed

Dosing: Adult

  • Motion sickness (adults): 30 mg 2 hours before travel, then 15 mg every 8 hours during the journey
  • Motion sickness (children 5 to 12 years): Half the adult dose
renalcarematters.com, reviewed

Dosing: Altered kidney function

Cinnarizine is extensively metabolized by the liver (CYP2D6); metabolites are excreted about one-third in urine and two-thirds in feces. The Irish label has no kidney studies and advises using it with care in kidney insufficiency, without a dose change. It has no US FDA label.

Kidney function measure: The SmPC does not grade kidney impairment; bands shown on creatinine clearance (CrCl).

Show full dosing details
CrCl ≥60 mL/min
Motion sickness: 30 mg 2 hours before travel, then 15 mg every 8 hours during the journey (SmPC).
CrCl 30–59 mL/min
No specific studies in kidney impairment; the SmPC says to use with care. Use with caution and specialist judgment.
CrCl 15–29 mL/min
No specific studies in kidney impairment; the SmPC says to use with care. Use with caution and specialist judgment.
CrCl <15 mL/min (not on dialysis)
No specific studies in kidney impairment; the SmPC says to use with care. Use with caution and specialist judgment.
Hemodialysis (intermittent)
Not studied in dialysis; no dose given.
Peritoneal dialysis
Not studied in dialysis; no dose given.
CRRT
Not studied in dialysis; no dose given.
  • Dialyzable? Not stated (91% protein-bound).
  • Monitoring Sedation (worse with alcohol and central nervous system depressants); extrapyramidal symptoms and parkinsonism, especially in older adults on long-term use (SmPC 4.4, 4.8).
Children (kidney dosing)
eGFR ≥60
No pediatric kidney data; use with care.
eGFR 30–59
No pediatric kidney data; use with care.
eGFR 15–29
No pediatric kidney data; use with care.
eGFR <15 (not on dialysis)
No pediatric kidney data; use with care.
Hemodialysis (intermittent)
No pediatric kidney data; use with care.
Peritoneal dialysis
No pediatric kidney data; use with care.
CRRT
No pediatric kidney data; use with care.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

Source: HPRA (Ireland) product information (March 2024). This generic has no US FDA label.

Dosing: Pediatric

Approved ages
Motion sickness: 5 to 12 years at half the adult dose (SmPC).
Usual dose
5 to 12 years: half the adult dose.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed

Dosage forms

Philippines

  • Tablet: 25 mg
  • Capsule: 75 mg
  • Film-coated tablet: 25 mg

Registered products in the Philippines

26 products registered with the Food and Drug Administration (FDA) Philippines list Cinnarizine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products26
Philippine FDA-registered products for Cinnarizine
Package insert
CinnablocCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Aldril Pharmaceuticals, Inc.
DRP-5330
Dec 13, 2029
CinnablocCinnarizine
75 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 10's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Aldril Pharmaceuticals, Inc.
DRP-5317
Dec 24, 2028
CinnarexCinnarizine
25 mg TabletBlister Pack x 20's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Roymed PharmaceuticalTrader: Westfield Pharmaceuticals, Inc.
DRP-1367-03
Feb 10, 2028
CinnarigoCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3100-04
Jul 5, 2029
CinzitabCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-5500
Sep 17, 2029
Dizzinon ForteCinnarizine
75 mg CapsuleAlu/Clear PVC Blister Pack of 10's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Justright Healthcare Inc.
DR-XY37385
Jan 21, 2030
EmecinCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-3100
Jul 5, 2029
GalcinarCinnarizine
25 mg TabletAlu/PVC Blister Pack x 20's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Beracah Pharma Phils., Inc.Trader: Foramen Products Corporation
DR-XY19388-B
Jul 17, 2027
GorizineCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Applied Pharmaceutical Distribution IncImporter: Ambica International Corporation
DRP-3100-03
Jul 5, 2029
LorizineCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
D & G PharmaImporter: Ambica International Corporation
DRP-3100-02
Jul 5, 2029
MoticonCinnarizine
25 mg TabletBlister Pack x 20's (Box of 100's)
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Westfield Pharmaceuticals, Inc.
DRP-1367
Feb 10, 2028
NoneCinnarizine
25 mg TabletAlu/PCTFE Blister Pack x 10's (Box of 30's)
Rx
UNILAB, INC.Philippines
Trader: RITEMED PHILS., INC.
DR-XY37211
Dec 18, 2029
NoneCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
XL Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-3100-05
Jul 5, 2029
NoneCinnarizine
25 mg TabletAlu/Clear PVC Blister pack x 20's (Box of 100's)
Rx
Drugmaker's Laboratories, Inc.Philippines
TGP Pharma Inc.
DRP-3967-01
Mar 3, 2029
NoneCinnarizine
25 mg TabletBlister Pack x 10's (Box of 100's)
Rx
Y.S.P. Industries (M) Sdn. Bhd.Malaysia
Ritemed Phils., Inc.
DRP-9409
Jul 15, 2028
NoneCinnarizine
75 mg CapsulePVC/PVTFE Alu Blister Pack (Box of 10's)
Rx
UNILAB, INC.Philippines
Trader: RITEMED PHILS., INC.
DR-XY38677
Oct 20, 2030
NoneCinnarizine
75 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 10's)
Rx
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Aldril Pharmaceuticals, Inc.
DRP-5317-02
Dec 24, 2028
RizineCinnarizine
25 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals, Inc.
DRP-14464
Sep 8, 2028
StugeronCinnarizine
25 mg TabletAlu/PVC Blister Pack x 20's (Box of 200's)
Rx
Janssen Korea Ltd.Republic of Korea
Zuellig Pharma CorporationImporter: Johnson & Johnson (Philippines), Inc.
DR-XY34825
Aug 20, 2028
StugeronCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 25's (Box of 200's)
Rx
Janssen Cilag S.p.A.Italy
Importer: Johnson & Johnson (Philippines), Inc.
DR-XY47759
Feb 28, 2027
Stugeron ForteCinnarizine
75 mg CapsuleClear PVC-Alu Blister pack of 10's Box of 100’s
Rx
Janssen Korea Ltd.Republic of Korea
Zuellig Pharma CorporationImporter: Johnson & Johnson (Philippines), Inc.
DR-XY40786
Mar 26, 2027
SynazinCinnarizine
75 mg CapsuleAlu/PVC Blister Pack x 10's (Box of 100’s)
Rx
Sydenham Laboratories, Inc.Philippines
Sydenham Pharmaceuticals, Inc.
DRP-635
May 9, 2027
VercinCinnarizine
75 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 10's)
Rx
Lloyd Laboratories, Inc.Philippines
Totalcare Pharma Inc.Trader: Aldril Pharmaceuticals, Inc.
DRP-5317-01
Dec 24, 2028
VercureCinnarizine
75 mg CapsuleAlu/Clear PVC Blister Pack x 10's (Box of 10's)
Rx
Lloyd Laboratories, Inc.Philippines
Randril International Co., Inc.Trader: Aldril Pharmaceuticals, Inc.
DRP-5317-03
Dec 24, 2028
VertexCinnarizine
25 mg TabletAlu/Clear PVC Blister pack x 20's (Box of 100's)
Rx
Drugmaker's Laboratories, Inc.Philippines
—
DRP-3967
Mar 3, 2029
VertisinCinnarizine
25 mg TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
Rx
Yu Sheng Pharmaceutical Co., Ltd.Taiwan
Littman Drug Corporation
DR-XY25924
Feb 9, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Drug interactions

Drug or classSeverityEffectWhat to do
Alcohol, central nervous system depressants, tricyclic antidepressantsAdjust or monitorMore sedation.Avoid alcohol; caution with depressants.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed

Adverse reactions

Common

  • Somnolence (9.9%)
  • Nausea (3.0%)
  • Weight gain (1.5%)

Serious

  • Extrapyramidal disorder, parkinsonism, dyskinesia
  • Cholestatic jaundice
  • Subacute cutaneous lupus erythematosus, lichen planus
renalcarematters.com, reviewed

Monitoring parameters

  • Sedation (worse with alcohol and central nervous system depressants); extrapyramidal symptoms and parkinsonism, especially in older adults on long-term use (SmPC 4.4, 4.8). Kidney
  • Sedation; extrapyramidal signs in older adults
renalcarematters.com, reviewed

Pharmacokinetics

Key PK parameters

Time to peak2.5 to 4 hours
Half-life4 to 24 hours
Protein binding91%
Metabolism (CYP, transporters)Extensive, mainly CYP2D6
Renal excretion kidneyMetabolites about one-third in urine, two-thirds in feces
Dialyzability kidneyNot stated
renalcarematters.com, reviewed

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Cinnarizine 25 mg Tablet₱0.65–₱1.50Reference ₱1.20per tabletDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Cinnarizine
PNF listingOral: 25 mg tablet
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Health Products Regulatory Authority (Ireland). Stugeron 15 mg tablets SmPC (PA23490/024/001) [HPRA (Ireland) product information, March 2024; no US FDA label]. https://assets.hpra.ie/products/Human/22248/Licence_PA23490-024-001_01032024124558.pdf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
  5. JNTL Consumer Health I (Ireland) Limited. (2024). Stugeron 15 mg tablets (cinnarizine) [Summary of product characteristics, licence PA23490/024/001; text revised March 2024]. Health Products Regulatory Authority (Ireland). https://assets.hpra.ie/products/Human/22248/Licence_PA23490-024-001_01032024124558.pdf

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .